Salix Pharmaceuticals Inc (SLXP)
Quote as of 4:00 PM ET 03/18/2010 (NASDAQ GS)
| Last: 30.68 |
Change: $.00 |
Percent Change: .00 |
Volume: 667,008 |
Salix Pharmaceuticals, Ltd. (Salix) is a specialty pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs used in the treatment of a variety of gastrointestinal diseases, which are affecting the digestive tract. The Company?s products include XIFAXAN, MOVIPREP, OSMOPREP, VISICOL, APRISO, METOZOLV, AZASAN, ANUSOL-HC, PROCTOCORT cream, PEPCID, Oral Suspension DIURIL and COLAZAL. The Company?s products under development include Rifaximin, Crofelemer, Balsalazide disodium tablet and Budesonide foam.
Latest News
12:01:00 AM 3/12/2010
Now is a good time to buy stocks
Historically, on average there have been two particularly auspicious times to buy stock each year. Right now is one of those times, writes Kevin Marder.
10:49:57 AM 3/10/2010
Salix expects big drop in sales
Mar 10, 2010 (The News and Observer - McClatchy-Tribune Information Services via COMTEX) --
Salix Pharmaceuticals' fourth-quarter revenue and net income slightly exceeded analysts' expectations, but the Raleigh company projected first-quarter numbers that were surprisingly low.
8:27:11 PM 2/24/2010
FDA panel boosts Salix
Feb 24, 2010 (The News & Observer - McClatchy-Tribune Information Services via COMTEX) --
Salix Pharmaceuticals shares jumped as much as 18 percent in after-hours trading Tuesday after the company's application to market its best-selling drug Xifaxan for a serious liver disease got a thumbs up from a Food and Drug Administration advisory panel.
7:53:00 PM 2/23/2010
Stocks in focus for Wednesday
Salesforce.com, Limited Brands and Saks Inc. are among the companies whose shares are expected to be active during Wednesday's trading session.